Virus safety of pasteurized antithrombin IIi concentrate
Roggendorf, M.; Delvos, U.; Nováková-Banet, A.
Thrombosis and Haemostasis 65(2): 212
1991
ISSN/ISBN: 0340-6245 PMID: 1647061 Document Number: 385518
Document emailed within 1 workday
Related Documents
Biescas, H.; Gensana, M.; Fernández, J.; Ristol, P.; Massot, M.; Watson, E.; Vericat, F. 1998: Characterization and viral safety validation study of a pasteurized therapeutic concentrate of antithrombin III obtained through affinity chromatography Haematologica 83(4): 305-311Dornheim, G.; Schön, R. 1982: Preparation and characterization of an antithrombin IIi concentrate Folia Haematologica 109(6): 870-877
Sacher, R.A. 1998: Potential applications of antithrombin concentrate in system inflammatory disorders. Introduction Blood Coagulation and Fibrinolysis: An International Journal in Haemostasis and Thrombosis 9 Suppl. 2: S1-S2
Patton, D.F.; Harper, J.L.; Wooldridge, T.N.; Gordon, B.G.; Coccia, P.; Haire, W.D. 1996: Treatment of veno-occlusive disease of the liver with bolus tissue plasminogen activator and continuous infusion antithrombin III concentrate Bone Marrow Transplantation 17(3): 443-447
Tekerlekov, P.; Popov, G.; Vasileva, L.; Nikolova, E. 1985: Experiments to purify and concentrate the foot-and-mouth disease virus Veterinarno-Meditsinski Nauki 22(10): 3-9
Arrighi, S.; Rossi, R.; Borri, M.G.; Lesnikov, V.; Lesnikova, M.; Franco, E.; Divizia, M.; De Santis, M.E.; Bucci, E. 1995: "In vitro" and in animal model studies on a double virus-inactivated factor VIII concentrate Thrombosis and Haemostasis 74(3): 868-873
Kessler, C.; Lusher, J.; Pierce, G.F.; Pierce, B.; Koerper, M.A.; Dickinson, J.C. 1995: Transmission of hepatitis C virus by monoclonal-purified viral-attenuated factor VIIi concentrate Lancet 346(8985): 1297-1298
Canales Albendea, M.A.; Villar Camacho, A.; Chamarro Merino, G.; Magallón Martínez, M. 1998: Ultrapure factor VIIi concentrate with double virus inactivation: study of pharmacokinetics in von Willebrand's disease patients Sangre 43(1): 93-94
Hammar, L.; Merza, M.; Malm, K.; Eriksson, S.; Morein, B. 1989: The use of aqueous two-phase systems to concentrate and purify bovine leukemia virus outer envelope protein gp51 Biotechnology and Applied Biochemistry 11(3): 296-306
Mannucci, P.M.; Zanetti, A.R.; Colombo, M.; Chistolini, A.; De Biasi, R.; Musso, R.; Tamponi, G. 1990: Antibody to hepatitis C virus after a vapour-heated factor VIIi concentrate. the Study Group of the Fondazione dell'Emofilia Thrombosis and Haemostasis 64(2): 232-234
Jeong, H.; Kim, M.; Lee, J.; Hahn, S.H.; Park, S.; Yoo, O.J. 1997: A 5-nucleotide insertion in the antithrombin gene causing a quantitative antithrombin deficiency Thrombosis and Haemostasis 77(1): 212-213
Gerhards, H. 1987: Antithrombin III determination in horses. Reference values and acquired antithrombin III deficiency Tierarztliche Praxis 15(1): 47-55
Fujimaki, M.; Nagasawa, H. 1974: Coagulation inhibitory factor: antithrombin--with special reference to antithrombin 3 Nihon Rinsho. Japanese Journal of Clinical Medicine 32(5): 942-947
Smith, M.P.; Rice, K.M.; Savidge, G.F. 1997: Successful clinical use of a plasma-derived, dual virus inactivated factor VII concentrate incorporating solvent-detergent and dry heat treatment Thrombosis and Haemostasis 77(2): 406-407
Lewandowski, J.J.; Galar, M.; Mazgajska-Barczyk, K.; Panek, M.; Kłoczko, J. 2002: Antithrombin III, protein C and thrombin/antithrombin IIi complexes (TAT) in patients suffering from chronic cholecystolithiasis treated by classical and laparoscopic cholecystectomy Polski Merkuriusz Lekarski: Organ Polskiego Towarzystwa Lekarskiego 13(74): 119-122
Russo, G.; Mertens, K.; De Magistris, L.; Lange, H.; Cortese, R.; Pietropaolo, C. 1991: Biologically active recombinant prothrombin and antithrombin IIi expressed in a human hepatoma/vaccinia virus system Biotechnology and Applied Biochemistry 14(2): 222-233
Rouzioux, C.; Chamaret, S.; Montagnier, L.; Carnelli, V.; Rolland, G.; Mannucci, P.M. 1985: Absence of antibodies to AIDS virus in haemophiliacs treated with heat-treated Factor VIIi concentrate Lancet 1(8423): 271-272
Haussmann, U.; Fischer, J.; Eber, S.; Scherer, F.; Seger, R.; Gungor, T. 2006: Hepatic veno-occlusive disease in pediatric stem cell transplantation: impact of pre-emptive antithrombin III replacement and combined antithrombin III/defibrotide therapy Haematologica 91(6): 795-800
Shinyama, H.; Akira, T.; Uchida, T.; Hirahara, K.; Watanabe, M.; Kagitani, Y. 1996: Antithrombin III prevents renal dysfunction and hypertension induced by enhanced intravascular coagulation in pregnant rats: pharmacological confirmation of the benefits of treatment with antithrombin III in preeclampsia Journal of Cardiovascular Pharmacology 27(5): 702-711
Lang, D.J.; Kovacs, A.A.; Zaia, J.A.; Doelkin, G.; Niland, J.C.; Aledort, L.; Azen, S.P.; Fletcher, M.A.; Gauderman, J.; Gjerset, G.J. 1989: Seroepidemiologic studies of cytomegalovirus and Epstein-Barr virus infections in relation to human immunodeficiency virus type 1 infection in selected recipient populations. Transfusion Safety Study Group Journal of Acquired Immune Deficiency Syndromes 2(6): 540-549